​

Glaukos (GKOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GKOS Stock Forecast

Glaukos (GKOS) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $192.89, with a high of $215.00 and a low of $150.00. This represents a 25.67% increase from the last price of $153.49.

$50 $90 $130 $170 $210 $250 High: $215 Avg: $192.89 Low: $150 Last Closed Price: $153.49

GKOS Stock Rating

Glaukos stock's rating consensus is Buy, based on 25 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (72.00%), 6 Hold (24.00%), 1 Sell (4.00%), and 0 Strong Sell (0.00%).

Buy
Total 25 1 6 18 Strong Sell Sell Hold Buy Strong Buy

GKOS Price Target Upside V Benchmarks

TypeNameUpside
StockGlaukos25.67%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks22.75%

Price Target Trends

1M3M12M
# Anlaysts11237
Avg Price Target$210.00$187.33$150.97
Last Closing Price$153.49$153.49$153.49
Upside/Downside36.82%22.05%-1.64%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 263101--14
Aug, 263101--14
Jul, 26310---13
Jun, 26310---13
May, 26310---13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 22, 2026Jefferies$210.00$162.2429.44%36.82%
Aug 20, 2026BTIG$202.00$189.556.57%31.60%
Jul 30, 2026H.C. Wainwright$195.00$170.6714.26%27.04%
Jul 30, 2026Stifel Nicolaus$190.00$161.6617.53%23.79%
Jul 30, 2026Matt O'BrienPiper Sandler$195.00$161.6620.62%27.04%
Jul 30, 2026Larry BiegelsenWells Fargo$178.00$161.6610.11%15.97%
Jul 30, 2026David SaxonNeedham$201.00$161.6624.34%30.95%
Jul 30, 2026Richard NewitterTruist Financial$215.00$161.6633.00%40.07%
Jul 28, 2026UBS$150.00$151.91-1.26%-2.27%
Jul 16, 2026Truist Financial$180.00$159.1713.09%17.27%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 22, 2026JefferiesBuyBuyhold
Aug 20, 2026BTIGBuyBuyhold
Jul 30, 2026H.C. WainwrightBuyBuyhold
Jul 30, 2026CitigroupBuyBuyhold
Jul 30, 2026Piper SandlerOverweightOverweighthold
Jul 30, 2026Wells FargoOverweightOverweighthold
Jul 30, 2026NeedhamBuyBuyhold
Jul 28, 2026UBSBuyNeutraldowngrade
Jul 13, 2026BTIGBuyBuyhold
Jul 08, 2026CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.07$-2.09$-2.78$-2.77----
Avg Forecast$-0.88$-2.20$-2.22$-1.82$-1.05$-0.25$0.42$1.18
High Forecast$-0.82$-2.02$-2.16$-1.71$-0.75$0.08$0.44$1.24
Low Forecast$-0.92$-2.30$-2.26$-2.00$-1.32$-0.38$0.39$1.12
Surprise %21.59%-5.00%25.23%52.20%----

Revenue Forecast

$250M $400M $550M $700M $850M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$294.01M$282.86M$314.71M$383.48M----
Avg Forecast$288.16M$279.63M$313.00M$378.54M$479.13M$609.94M$745.10M$916.05M
High Forecast$299.38M$289.59M$313.16M$378.96M$499.83M$610.76M$776.53M$954.70M
Low Forecast$273.19M$261.89M$312.87M$377.81M$458.02M$609.12M$713.86M$877.64M
Surprise %2.03%1.16%0.55%1.31%----

Net Income Forecast

$-200M $-140M $-80M $-20M $40M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.59M$-99.19M$-134.66M$-146.37M----
Avg Forecast$-60.89M$-56.35M$-134.66M$-89.64M$-50.13M$-7.30M$20.10M$57.15M
High Forecast$-45.79M$-39.19M$-95.11M$-82.63M$-36.24M$4.00M$21.20M$60.29M
Low Forecast$-75.99M$-73.50M$-174.21M$-96.64M$-64.01M$-18.60M$19.00M$54.04M
Surprise %-18.55%76.04%-63.29%----

GKOS Forecast FAQ

Is Glaukos stock a buy?

Glaukos stock has a consensus rating of Buy, based on 25 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Glaukos is a favorable investment for most analysts.

What is Glaukos's price target?

Glaukos's price target, set by 25 Wall Street analysts, averages $192.89 over the next 12 months. The price target range spans from $150 at the low end to $215 at the high end, suggesting a potential 25.67% change from the previous closing price of $153.49.

How does Glaukos stock forecast compare to its benchmarks?

Glaukos's stock forecast shows a 25.67% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (22.75%).

What is the breakdown of analyst ratings for Glaukos over the past three months?

  • September 2026: 21.43% Strong Buy, 71.43% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 21.43% Strong Buy, 71.43% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 23.08% Strong Buy, 76.92% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Glaukos’s EPS forecast?

Glaukos's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.05, marking a -62.09% decrease from the reported $-2.77 in 2024. Estimates for the following years are $-0.25 in 2026, $0.42 in 2027, and $1.18 in 2028.

What is Glaukos’s revenue forecast?

Glaukos's average annual revenue forecast for its fiscal year ending in December 2025 is $479.13M, reflecting a 24.94% increase from the reported $383.48M in 2024. The forecast for 2026 is $609.94M, followed by $745.1M for 2027, and $916.05M for 2028.

What is Glaukos’s net income forecast?

Glaukos's net income forecast for the fiscal year ending in December 2025 stands at $-50.125M, representing a -65.75% decrease from the reported $-146M in 2024. Projections indicate $-7.3M in 2026, $20.1M in 2027, and $57.15M in 2028.